Techas Capital is an innovative, purpose-driven investment firm making capital investments in companies based in the United States.
Mentions in press and media 3
| Date | Title | Description |
| 31.10.2025 | Curve Biosciences Ignites New Era in Chronic Disease Care with $40M Funding | Curve Biosciences recently secured $40M in Series A funding. This capital fuels its Whole-Body Intelligence platform. The platform uses the proprietary Whole-Body Atlas, a vast collection of tissue samples. It powers advanced Whole-Body Blo... |
| 30.10.2025 | Curve Biosciences: $40 Million Raised To Advance Whole-Body Intelligence Platform for Chronic Disease Monitoring | Curve Biosciences, a biotechnology company pioneering Whole-Body Intelligence for proactive and personalized chronic disease care, has raised $40 million in new funding led by Luma Group, with participation from First Spark Ventures, Techas... |
| 29.10.2025 | Curve Biosciences Secures $40M to Launch Whole-Body Intelligence Platform | What You Should Know: – Curve Biosciences, the Whole-Body Intelligence™ company, today announced it has raised $40M in Series A funding led by Luma Group, with participation from First Spark Ventures, Techas Capital, Civilization Ventures, ... |